Firstword - Plus Light Edition?pslrid=CE0218B085ED43A0ADBF1568395B15CF - Where people who know first, go first
    Industry News
    E-mail this article   E-mail this article  Print this article   Print this article   
November 05, 2009
IMS Health to be sold for $5.2 billion
by Matthew Dennis

IMS Health announced Thursday that it agreed to be acquired by investment funds TPG Capital and CPP Investment Board in a deal valued at $5.2 billion. IMS CEO David Carlucci said the sale of the company, which is expected to close in the first quarter of 2010, would allow it to “continue [its] focus on expanding into new markets” and assume “a bigger role in the healthcare market.”

The company said the deal, under which shareholders will receive $22.00 per share, represents a premium of around 50 percent over the closing price on October 16, when speculation surfaced that the company may be put up for sale. The healthcare data company noted in a statement that the offer price includes the assumption of debt, which IMS reported last month stood at $1.34 billion as of September 30.

Charles Bobrinskoy, vice chairman at Ariel Investments, which is IMS’ largest shareholder, said the investment fund “would strongly support a transaction at the price being discussed.”

Reference Articles

 IMS Health to be bought for $4 billion - (ABC News)
 IMS Health said to sell itself to TPG for about $4 billion - (Bloomberg)
 TPG, Canada Pension near $4 bln IMS buyout -source - (Forbes)
 IMS Health to be acquired by TPG and CPP Investment Board - (IMS Health)
 IMS Health agrees to $5 billion buyout from TPG - (MarketWatch)
 CPP eyes $4-billion LBO deal - (The Globe and Mail)
 IMS Health nears LBO deal (free preview) - (The Wall Street Journal)



 
FirstWord PLUS Companies mentioned in this article:
IMS




 

Most Read Stories in the Past Week

  GlaxoSmithKline announces revised payment model for US sales reps
  Momenta responds to sanofi-aventis court action over generic Lovenox
  FDA panel recommends approval of AstraZeneca's Brilinta
  Teva records 53 percent rise in 2Q net income
  Analysts comment on impact of Medicare cost plan for kidney dialysis

FirstWord Radio: Listen to up to the minute news throughout the day
Terms of Use | Privacy Policy | All Contents Copyright © 2010 Doctor's Guide Publishing Limited. All Rights Reserved.